Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
Recruitment status was: Active, not recruiting
RATIONALE: New diagnostic procedures, such as bioelectric field imaging, may help find and diagnose melanoma and other skin cancers. It may also be a less invasive way to check for skin cancer.
PURPOSE: This phase I trial is studying bioelectric field imaging in diagnosing melanoma and other skin cancers in patients with skin lesions.
|Melanoma (Skin) Non-melanomatous Skin Cancer||Procedure: bioelectric field imaging Procedure: biopsy Procedure: histopathologic examination||Phase 1|
|Study Design:||Primary Purpose: Diagnostic|
|Official Title:||Development of an Electrical Diagnostic for Melanoma and Other Cutaneous Malignancies|
- Use of Bioelectric Field Imager (BFI) in measuring the electric field in skin of various body surfaces
- Use of BFI in detecting significant electric field differences between malignant and benign skin lesions
|Study Start Date:||October 2006|
|Estimated Study Completion Date:||April 2007|
|Estimated Primary Completion Date:||April 2007 (Final data collection date for primary outcome measure)|
- To determine if the hand-held Bioelectric Field Imager can be used to measure the electric field in skin of various body surfaces, including face, neck, shoulders, arms, hands, chest, back, legs, and feet, during the course of examination and treatment of patients with suspected malignant skin lesions.
- To determine if there is a significant difference between the lateral electric field strength near benign and malignant skin lesions in the same individual.
OUTLINE: Patients undergo scanning of their skin lesions and nearby healthy skin using the Bioelectric Field Imager (BFI). The lesions are then biopsied for histological diagnosis. Histological data from the biopsy is correlated with the electric field data from the BFI.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00391300
|United States, Virginia|
|Hampton, Virginia, United States, 23667|
|Principal Investigator:||Antoinette F. Hood, MD||Eastern Virginia Medical School|